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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to zinc 
and “the prevention of bad breath by neutralising of volatile sulphur 
compounds in the mouth and oral cavity” pursuant to Article 13(5) of 
Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from EJP Pharmaceutical ApS, submitted pursuant to Article 13(5) of Regulation (EC) 
No 1924/2006 via the Competent Authority of Denmark, the Panel on Dietetic Products, Nutrition and Allergies 
was asked to deliver an opinion on the scientific substantiation of a health claim related to zinc and “the 
prevention of bad breath by neutralising of volatile sulphur compounds in the mouth and oral cavity”. The scope 
of the application was proposed to fall under a health claim based on newly developed scientific evidence. The 
claimed effect is “prevents bad breath by neutralising of volatile sulphur compounds in the mouth and oral 
cavity”. The target population, as proposed by the applicant, is adults over the age of 18 who wish to improve 
their bad breath. The Panel considers that the proposed claim is related to breath odour rather than to a function 
of the body as required by Article 13 of Regulation (EC) No 1924/2006. The Panel considers that the claim does 
not comply with the criteria laid down in Regulation (EC) No 1924/2006. © European Food Safety Authority, 
2011 
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1  On request from the Competent Authority of Denmark following an application by EJP Pharmaceutical ApS, Question No 
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2  Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, 
Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, 
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Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van 
Loveren and Hans Verhagen for the preparatory work on this scientific opinion. 
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SUMMARY 
Following an application from EJP Pharmaceutical ApS, submitted pursuant to Article 13(5) of 
Regulation (EC) No 1924/2006 via the Competent Authority of Denmark, the Panel on Dietetic 
Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a 
health claim related to zinc and “the prevention of bad breath by neutralising of volatile sulphur 
compounds in the mouth and oral cavity”. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. 
The claimed effect is “prevents bad breath by neutralising of volatile sulphur compounds in the mouth 
and oral cavity”. The target population, as proposed by the applicant, is adults over the age of 18 who 
wish to improve their bad breath. 
The Panel notes that health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 are 
required to describe or refer to, among other roles, the role of a nutrient or other substance in the 
functions of the body. Thus, the applicant was requested to clarify how the proposed claim might 
comply with this requirement. The applicant replied by expressing the view that the production of 
volatile sulphur compounds and halitosis as part of the bacterial flora of the mouth and oral cavity is 
related to the function of the mouth and oral cavity, and thus to a function of the body. The Panel 
notes that the applicant did not provide any additional evidence that the chemical neutralisation of 
volatile sulphur compounds in the mouth in order to improve bad breath constitutes a physiological 
effect in relation to a function of the body. 
The Panel considers that the claim “prevents bad breath by neutralising of volatile sulphur compounds 
in the mouth and oral cavity” is related to breath odour rather than to a function of the body as 
required by Article 13 of Regulation (EC) No 1924/2006. 
The Panel considers that the claim does not comply with the criteria laid down in Regulation (EC) No 
1924/2006.
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Regulation (EC) No 1924/2006
4
 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of 
this Regulation, are authorised in accordance with this Regulation and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this 
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to children’s development and health) which are based on newly developed 
scientific evidence, or which include a request for the protection of proprietary data, to the 
Community list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted claims referred to in Art 13(3) shall be submitted by the applicant to the national competent 
authority of a Member State, which will make the application and any supplementary information 
supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA 
 The application was received on 03/09/2010. 
 EFSA sent a request for clarification to the Competent Authority of Denmark on 11/10/2010. 
 The Competent Authority of Denmark provided its reply to EFSA on 01/03/2011. 
 A revised application was received on 01/03/2011. 
 The scope of the application was proposed to fall under a health claim based on newly 
developed scientific evidence. 
 The scientific evaluation procedure started on 20/03/2011. 
 EFSA sent a request for information to the applicant on 30/03/2011. 
 The applicant provided a reply to EFSA on 15/04/2011. 
 During the meeting on 13/05/2011, the NDA Panel, having evaluated the data submitted, 
adopted an opinion on the scientific substantiation of a health claim related to zinc and “the 
prevention of bad breath by neutralising of volatile sulphur compounds in the mouth and oral 
cavity”. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: zinc and “the prevention of bad 
breath by neutralising of volatile sulphur compounds in the mouth and oral cavity”. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation to the marketing 
of zinc, a positive assessment of its safety, nor a decision on whether zinc is, or is not, classified as a 
foodstuff. It should be noted that such an assessment is not foreseen in the framework of Regulation 
(EC) No 1924/2006. 
                                                     
4 European Parliament and Council (2006). Regulation (EC) No 1924/2006 of the European Parliament and of the Council 
of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union OJ L 404, 
30.12.2006. Corrigendum OJ L 12, 18.1.2007, p. 3–18. 
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It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: EJP Pharmaceutical ApS, Ulvshalevej 70, 4780 Stege, Denmark. 
Food/constituent as stated by the applicant 
According to the applicant, zinc was identified as the food/constituent. 
Health relationship as claimed by the applicant 
According to the applicant, zinc reduces or inhibits oral malodour via its interaction with sulphur. The 
proposed mechanism is that the zinc ions oxidize the thiol groups in the precursors of volatile sulphur-
containing compounds resulting from the microbial degradation of oral organic substrates. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the claim: “Prevents bad breath by neutralising 
of volatile sulphur compounds (VSC) in the mouth and oral cavity”. 
Specific conditions of use as proposed by the applicant 
The applicant has proposed a maximum of one lozenge containing 6.8 mg zinc per day. The lozenge 
should be kept in the mouth until dissolved (for approximately 10 min). The target population, as 
proposed by the applicant, is adults over the age of 18 who wish to improve their bad breath. 
ASSESSMENT 
1. Characterisation of the food/constituent 
The food constituent that is the subject of the health claim is zinc. 
Zinc is a well recognised nutrient and is measurable in foods by established methods. Zinc occurs 
naturally in foods and is authorised for addition to foods (Annex I of the Regulation (EC) No 
1925/2006
5
 and Annex I of Directive 2002/46/EC
6
). This evaluation applies to zinc naturally present 
in foods and those forms authorised for addition to foods (Annex II of the Regulation (EC) No 
1925/2006 and Annex II of Directive 2002/46/EC). 
The Panel considers that the food constituent, zinc, which is the subject of the health claim, is 
sufficiently characterised. 
2. Relevance of the claimed effect to human health 
The claimed effect is “prevents bad breath by neutralising of volatile sulphur compounds in the mouth 
and oral cavity”. The target population, as proposed by the applicant, is adults over 18 years of age 
who wish to improve their bad breath. 
                                                     
5 Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404, 30.12.2006, p. 26–38. 
6 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183, 12.7.2002, p. 51–57. 
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The Panel notes that health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 are 
required to describe or refer to, among other roles, the role of a nutrient or other substance in the 
functions of the body. 
Thus, the applicant was requested to clarify how the proposed claim might comply with this 
requirement. The applicant replied by expressing the view that the production of volatile sulphur 
compounds and halitosis as part of the bacterial flora of the mouth and oral cavity is related to the 
function of the mouth and oral cavity, and thus to a function of the body. The Panel notes that the 
applicant did not provide any additional evidence that the chemical neutralisation of volatile sulphur 
compounds in the mouth in order to improve bad breath constitutes a physiological effect in relation 
to a function of the body. 
The Panel considers that the claim “prevents bad breath by neutralising of volatile sulphur compounds 
in the mouth and oral cavity” is related to breath odour rather than to a function of the body as 
required by Article 13 of Regulation (EC) No 1924/2006. 
The Panel considers that the claim does not comply with the criteria laid down in Regulation (EC) No 
1924/2006. 
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food constituent, zinc, which is the subject of the health claim, is sufficiently 
characterised. 
 The claimed effect is “prevents bad breath by neutralising of volatile sulphur compounds in 
the mouth and oral cavity”. The target population, as proposed by the applicant, is adults over 
the age of 18 who wish to improve their bad breath. 
 The claim is related to breath odour rather than to a function of the body as required by 
Article 13 of Regulation (EC) No 1924/2006. The claim does not comply with the criteria laid 
down in Regulation (EC) No 1924/2006. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on zinc and “prevents bad breath by neutralising of volatile sulphur 
compounds in the mouth and oral cavity” pursuant to Article 13(5) of Regulation (EC) No 1924/2006 
(Claim serial No: 0290_DK). September 2010. Submitted by EJP Pharmaceutical ApS. 
